Integrative genomic/epigenomic analysis in clear cell ovarian cancers

被引：0
|
作者：
Oda, Katsutoshi [1 ]
Nishijima, Akira [2 ]
Hasegawa, Kosei [3 ]
Aburatani, Hiroyuki
机构：
[1] Univ Tokyo, Integrat Genom, Tokyo, Japan
[2] Univ Tokyo, Dept Ob&Gyn, Tokyo, Japan
[3] Saitama Med Univ, Int Med Ctr, Dept Gyn Oncol, Saitama, Japan
来源：
CANCER SCIENCE | 2022年 / 113卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
S11-5
引用
收藏
页码：708 / 708
页数：1
相关论文
共 50 条
  • [41] Identification of Novel Therapeutic Targets in Microdissected Clear Cell Ovarian Cancers
    Stany, Michael P.
    Vathipadiekal, Vinod
    Ozbun, Laurent
    Stone, Rebecca L.
    Mok, Samuel C.
    Xue, Hui
    Kagami, Takashi
    Wang, Yuwei
    McAlpine, Jessica N.
    Bowtell, David
    Gout, Peter W.
    Miller, Dianne M.
    Gilks, C. Blake
    Huntsman, David G.
    Ellard, Susan L.
    Wang, Yu-Zhuo
    Vivas-Mejia, Pablo
    Lopez-Berestein, Gabriel
    Sood, Anil K.
    Birrer, Michael J.
    PLOS ONE, 2011, 6 (07):
  • [42] Integrative Bioinformatical Analysis of Clear Cell Renal Cell Carcinoma
    Yousef, George
    Butz, Henriett
    Szabo, Peter
    Mozes, Roy
    Rotondo, Fabio
    Kovacs, Kalman
    Patocs, Attila
    MODERN PATHOLOGY, 2015, 28 : 403A - 403A
  • [43] Integrative Bioinformatical Analysis of Clear Cell Renal Cell Carcinoma
    Yousef, George
    Butz, Henriett
    Szabo, Peter
    Mozes, Roy
    Rotondo, Fabio
    Kovacs, Kalman
    Patocs, Attila
    LABORATORY INVESTIGATION, 2015, 95 : 403A - 403A
  • [44] Genomic analysis of clear cell carcinoma.
    Haribhakti, Nirav
    Elliott, Andrew
    Walker, Phillip
    Marks, Eric I.
    El-Deiry, Wafik S.
    Kurzrock, Razelle
    Girda, Eugenia
    Thaker, Premal H.
    Korn, Wolfgang Michael
    Liu, Stephen V.
    Dizon, Don S.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [45] Do clear cell ovarian carcinomas have poorer prognosis compared to other epithelial cell types? A study of 1411 clear cell ovarian cancers
    Chan, John K.
    Teoh, Deanna
    Hu, Jessica M.
    Shin, Jacob Y.
    Osann, Kathryn
    Kapp, Daniel S.
    GYNECOLOGIC ONCOLOGY, 2008, 109 (03) : 370 - 376
  • [46] Ovarian Clear Cell Carcinoma: Genomic Characterization, Pathogenesis and Targeted Therapy
    Xie, Yunkai
    Kong, Weimin
    Luo, Dan
    Chen, Shuning
    Zhao, Xiaoling
    Zhang, He
    ANTICANCER RESEARCH, 2023, 43 (08) : 3401 - 3410
  • [47] Spatial heterogeneity of the actionable genomic alterations in ovarian clear cell carcinoma
    Takenaka, Masataka
    Kamii, Misato
    Kuroda, Takafumi
    Kawabata, Ayako
    Takahashi, Kazuaki
    Yanaihara, Nozomu
    Okamoto, Aikou
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2023, 33 (SUPPL_4) : A204 - A204
  • [48] Identification of cellular networks for chemoresistance of ovarian clear cell cancers through single nucleus analysis.
    Mori, Yutaro
    Yamawaki, Kaoru
    Ishiguro, Tatsuya
    Yoshihara, Kosuke
    Kanda, Yusuke
    Shiokawa, Daisuke
    Enomoto, Takayuki
    Okamoto, Koji
    CANCER SCIENCE, 2021, 112 : 375 - 375
  • [49] Integrative genomic, transcriptomic and functional genomic analysis identifies novel therapeutic targets for breast cancers
    Reis-Filho, Jorge
    JOURNAL OF MEDICAL GENETICS, 2009, 46 : S35 - S35
  • [50] Integrative Analysis of the Genomic and Immune Microenvironment Characteristics Associated With Clear Cell Renal Cell Carcinoma Progression: Implications for Prognosis and Immunotherapy
    Lin, Enyu
    Zhu, Ping
    Ye, Chujin
    Huang, ManLi
    Liu, Xuechao
    Tian, Kaiwen
    Tang, Yanlin
    Zeng, Jiayi
    Cheng, Shouyu
    Liu, Jiumin
    Liu, Yanjun
    Yu, Yuming
    FRONTIERS IN IMMUNOLOGY, 2022, 13
12345